Indication
Adenosine deaminase severe combined immune deficiency
Adenosine deaminase severe combined immune deficiency is an autosomal recessive inborn error of metabolism and primary immunodeficiency caused by mutations in the *ADA* gene. Read more about Adenosine deaminase severe combined immune deficiency
6 drugs 5 manufacturers
Drugs that treat it
Common Adenosine deaminase severe combined immune deficiency therapies.
ADAGEN (pegademase bovine)
ADAGEN (pegademase bovine)
REVCOVI (elapegademase-lvlr)
REVCOVI (elapegademase-lvlr)
REVCOVI (elapegademase-lvlr)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAdenosine deaminase severe combined immune deficiency is an autosomal recessive inborn error of metabolism and primary immunodeficiency caused by mutations in the *ADA* gene.
The deficiency of the adenosine deaminase enzyme causes intracellular accumulation of toxic purine metabolites, primarily deoxyadenosine and deoxyadenosine triphosphate, which trigger premature apoptosis of rapidly dividing lymphocytes.
This leads to profound, combined T-, B-, and natural killer-cell lymphopenia and secondary systemic abnormalities.
Primarily affecting infants within the first six months of life, the condition is clinically characterized by severe failure to thrive, persistent diarrhea, and life-threatening, recurrent opportunistic infections.
- nih.gov
Adenosine deaminase severe combined immune deficiency is an autosomal recessive inborn error of metabolism and primary immunodeficiency caused by mutations in the *ADA* gene This leads to profound, combined T-, B-, and natural killer-cell lymphopenia and secondary systemic abnormalities
- youtube.com
Adenosine deaminase severe combined immune deficiency is an autosomal recessive inborn error of metabolism and primary immunodeficiency caused by mutations in the *ADA* gene
- leadiant.com
Adenosine deaminase severe combined immune deficiency is an autosomal recessive inborn error of metabolism and primary immunodeficiency caused by mutations in the *ADA* gene
- medlineplus.gov
The deficiency of the adenosine deaminase enzyme causes intracellular accumulation of toxic purine metabolites, primarily deoxyadenosine and deoxyadenosine triphosphate, which trigger premature apoptosis of rapidly dividing lymphocytes
- nih.gov
The deficiency of the adenosine deaminase enzyme causes intracellular accumulation of toxic purine metabolites, primarily deoxyadenosine and deoxyadenosine triphosphate, which trigger premature apoptosis of rapidly dividing lymphocytes
- revcovi.com
The deficiency of the adenosine deaminase enzyme causes intracellular accumulation of toxic purine metabolites, primarily deoxyadenosine and deoxyadenosine triphosphate, which trigger premature apoptosis of rapidly dividing lymphocytes
- nih.gov
This leads to profound, combined T-, B-, and natural killer-cell lymphopenia and secondary systemic abnormalities
- medlineplus.gov
Primarily affecting infants within the first six months of life, the condition is clinically characterized by severe failure to thrive, persistent diarrhea, and life-threatening, recurrent opportunistic infections
- cancer.gov
Primarily affecting infants within the first six months of life, the condition is clinically characterized by severe failure to thrive, persistent diarrhea, and life-threatening, recurrent opportunistic infections
- nih.gov
Primarily affecting infants within the first six months of life, the condition is clinically characterized by severe failure to thrive, persistent diarrhea, and life-threatening, recurrent opportunistic infections
Personalize your experience
Follow Adenosine deaminase severe combined immune deficiency and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.